Five Prime Therapeutics is a biotechnology company focused on the discovery and development of protein therapeutics, it was acquired by Amgen in 2021.
3
Funding Rounds
$55.0m
Money raised
The company Five Prime Therapeutics has raised a total of $55m in funding over 3 rounds.